Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:35 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1873–1896 of 3,253 matching trials from the live ClinicalTrials.gov search.

Filters: Not yet recruiting Clear all

Conditions: Ulnar Nerve Transposition
Interventions: Stiff splint, No splint; Procedure
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 5
States / cities: Calumet City, Illinois • Hyde Park, Illinois • Orland Park, Illinois + 2 more

Conditions: Continuous Glucose Monitoring, Type 1 Diabetes, Type 2 Diabetes
Interventions: FreeStyle Libre 3 Plus Continuous Glucose Monitor; Device
Lead sponsor: University of the Pacific; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Stockton, California

Conditions: Post-inflammatory Hyperpigmentation, Post-acne Hyperpigmentation
Interventions: Vinoperfect brightening serum; Other
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Hypertension, Obesity
Interventions: CagriSema, Semaglutide, Cagrilintide, Placebo; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 1,408 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 57
States / cities: Concord, California • Costa Mesa, California • Fullerton, California + 47 more

Conditions: Sanfilippo Syndrome Type C, Mucopolysaccharidosis (MPS) IIIC
Interventions: Not listed
Lead sponsor: Phoenix Nest; Industry
Eligibility: 1 Year to 25 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Lethal Means Safety, Brief Intervention, Concern Significant Others
Interventions: The Family Firearms Secure storage Training (FFAST) Intervention, Health and Stress Counseling; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 80 Years
Enrollment: 176 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: ASCVD, Hyperlipidemia, Hypertension
Interventions: Referral to the Duke Cardiometabolic Prevention Clinic; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Heart Failure With Preserved Ejection Fraction, Iron Deficiency
Interventions: Ferric derisomaltose, Placebo (normal saline); Drug
Lead sponsor: Duke University; Other
Eligibility: 65 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Early-stage Breast Cancer, Hypoactive Sexual Desire Disorder, Hormone Receptor Positive Breast Carcinoma, Breast Cancer
Interventions: Aromatase Inhibitors, Bupropion, GnRH agonist; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: ACL Tears
Interventions: MRI; Diagnostic Test
Lead sponsor: Skye Biologics Holdings, LLC; Industry
Eligibility: 14 Years to 50 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Sugar Land, Texas

Conditions: Tinnitus, Chronic Subjective Tinnitus
Interventions: Nicotine polacrilex gum 4 mg, Placebo gum; Drug · Other
Lead sponsor: San Diego State University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: San Diego, California

Conditions: Stroke, Chronic Stroke Patients, Arm Weakness as a Consequence of Stroke
Interventions: kTMP sham stimulation 9 weeks + active stimulation 9 weeks, kTMP 18 weeks; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Health and Wellness
Interventions: Not listed
Lead sponsor: Dr. Goodenowe Research LLC; Industry
Eligibility: 2 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2034
U.S. locations: 1
States / cities: Temecula, California

Conditions: Intraoperative Hypotension
Interventions: E-Fusion Vasopressor Titration-Assist; Device
Lead sponsor: Autonomous Healthcare, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Disruptive Behaviors
Interventions: Behavioral Parent Training; Behavioral
Lead sponsor: San Diego State University; Other
Eligibility: 2 Years to 6 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 2
States / cities: San Diego, California

Conditions: Low-level Blast Exposure
Interventions: Not listed
Lead sponsor: Uniformed Services University of the Health Sciences; Federal
Eligibility: 18 Years to 50 Years
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 3
States / cities: Bethesda, Maryland • Fort Bragg, North Carolina • San Antonio, Texas

Conditions: Osteonecrosis, Avascular Necrosis
Interventions: Hyperbaric Oxygen Therapy; Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2035
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Dry Eye Syndrome
Interventions: LacriFill Canalicular Filler; Device
Lead sponsor: Mann Eye Institute; Other
Eligibility: 18 Years to 39 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Chronic Low-back Pain (cLBP), High-Impact Chronic Pain (HICP)
Interventions: ENCompaSS (Education, Navigated Care, and Supported Self-Management) with VA Stepped Usual Care; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 530 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Opioid Use Disorder, Alcohol Intoxication, Pain
Interventions: Alcohol, Placebo; Drug
Lead sponsor: Ohio State University; Other
Eligibility: 21 Years to 65 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Vaccine Adverse Reaction, Post Acute Covid-19 Vaccination Syndrome
Interventions: Combined metabolic modulator, Rice Protein Powder with Vitamin C; Combination Product · Dietary Supplement
Lead sponsor: Independent Medical Alliance; Other
Eligibility: 16 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Parkinson's Disease (PD), Early Onset Parkinson Disease
Interventions: AAV2-hAADC; Drug
Lead sponsor: Russell Lonser; Other
Eligibility: 18 Years to 75 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Crohn Disease (CD), Crohns Disease, Ulcerative Colitis (UC)
Interventions: Mirikizumab; Biological
Lead sponsor: Rubix LS; Industry
Eligibility: 60 Years to 99 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Lawrence, Massachusetts

Conditions: Obesity & Overweight
Interventions: gut-brain axis (GLP-1)-activating food carbohydrate, starch-based placebo control (commercial maltodextrin); Drug · Other
Lead sponsor: Indiana University; Other
Eligibility: 12 Years to 18 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Indianapolis, Indiana

Search by objective public record fields.

Is Splinting After Ulnar Nerve Transposition Necessary?

Inter-Arm Differences in Continuous Glucose Monitor Readings in Adults With Diabetes

Evaluating a Brightening Serum for Post-Inflammatory Hyperpigmentation

A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity

Natural History to Assess Disease in Patients With MPS IIIC

Testing Family Firearm Secure Storage Training (FFAST) to Prevent Suicide

Duke Cardiometabolic Prevention Clinic's Impact on High-risk Cardiovascular Patients With Uncontrolled Risk Factors

IV Iron Therapy for Older Adults With Heart Failure With Preserved Ejection Fraction and Iron Deficiency

BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder

MRI Evaluation of Graft Maturation Following ACL Reconstruction

Acute Nicotine Gum and Auditory Brain Responses in Adults With Chronic Tinnitus

kTMP in Chronic Stroke

Wellness Program Participation and Changes in Health and Quality of Life in Adults and Children

Feasibility Study of E-Fusion Vasopressor Titration-Assist During Multi-Level Spine Surgery

Hybrid Pilot of Personalized Parent-Child Interaction Therapy

Blast Overpressure Longitudinal Study

Effect of HBOT on Femoral Head Avascular Necrosis (AVN)

LacriFill Canalicular Occlusion for Dry Eye After LASIK

Comparing Non-Medicine Strategies for Improving Low Back Pain

Pain Sensitivity, Alcohol-Induced Analgesia, and Heavy Drinking in Individuals With Opioid Use Disorder

Effect of Metabolic Modulation on a Post-acute COVID-19 Vaccination Syndrome (PACVS) Cohort

AAV2-hAADC for Parkinson's Disease (PDCS-01)

Evaluating the Efficacy and Safety of Mirikizumab in Adults Over 60 With Moderate to Severe Crohn's Disease and Ulcerative Colitis

Supplementation of Gut-brain Axis (GLP-1)-Activating Carbohydrates for Increasing Satiety in Adolescents With Obesity